EL
59
4
CMCSA
44
2
DE
78
2
AAPL
50
2
D
45
2
CL
58
2
EA
38
2
COF
49
2
CB
53
2
AES
72
4
CPB
47
2
ADT
58
2
EMN
58
3
BK
65
2
AMT
47
2
CSCO
60
2
ADSK
47
2
ESS
25
3
BF.B
57
4
AIV
19
-4
EL
59
4
CMCSA
44
2
DE
78
2
AAPL
50
2
D
45
2
CL
58
2
EA
38
2
COF
49
2
CB
53
2
AES
72
4
CPB
47
2
ADT
58
2
EMN
58
3
BK
65
2
AMT
47
2
CSCO
60
2
ADSK
47
2
ESS
25
3
BF.B
57
4
AIV
19
-4
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$86.40
Seasonality Move:
1.24%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 27.5% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $86.41. The Score for BIB is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • BIB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 27.5% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Buy
68
ProShares Ultra Nasdaq Biotechnology (BIB) is a Buy

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
89.06
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
86.41
Volume:
7.4K
Beta:
1.81

Technical Analysis

SMA50:
82.91
SMA100:
76.58
SMA200:
63.22
52-Wk Change:
51.33%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 86.41 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-2 83.92 84.97 84.99 83.87
Feb-3 83.75 84.81 87.56 83.75
Feb-4 85.28 85.24 85.65 83.99
Feb-5 84.59 81.74 87.21 81.38
Feb-6 83.58 86.66 86.66 83.58
Feb-9 85.78 86.28 86.42 84.72
Feb-10 85.88 84.13 86.29 84.13
Feb-11 83.79 84.87 85.07 81.74
Feb-12 85.04 83.09 85.04 82.56
Feb-13 84.60 84.72 87.08 84.54
Feb-17 86.33 86.20 86.55 84.83
Feb-18 86.68 87.05 87.50 86.68
Feb-19 87.49 87.38 87.49 83.98
Feb-20 86.84 86.41 87.08 85.73

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.